To improve knowledge of epidemiological data, management, and clinical outcome of acute heart failure (AHF) in a real-life setting in France.
Introduction
Acute heart failure (AHF) is a leading cause of hospitalization of adults ≥ 65 years of age in western countries, accounting for at least 3‰ inhabitants each year 1 and thus representing a major burden on the medical system and health costs. It is also associated with significant in-hospital mortality as well as high rates of death or rehospitalization after discharge, suggesting that there is room for improvement of care. 2 -6 The first step for improvement is to describe the current status of the disease as accurately and as close to the real life situation as possible. AHF represents a broad spectrum of clinical presentations from acute onset of severe pulmonary oedema to a gradual worsening of symptoms in chronic HF, and this has led to various definitions of the condition. 7 -9 AHF encompasses various pathophysiological issues as well as different management, including non-cardiological care. For these reasons, it is still difficult to define clear guidelines or make significant medical progress in this field. 10 -12 To answer some of these questions, the Heart Failure Working Group of the French Society of Cardiology designed the OFICA (Observatoire Français de l'Insuffisance Cardiaque Aiguë) as a single-day large snapshot of all patients with ongoing hospitalization for AHF in a nationwide and representative sample of French hospitals. Our aims were to investigate patient course before admission, clinical patterns, biological characteristics, treatment at discharge, and determinants of in-hospital survival.
Methods
We designed this survey as a single-day snapshot for reasons of feasibility, optimal representation of hospitals, and relative completeness of inclusions.
Hospitals and patients
Among the 450 French hospitals dealing with adult cardiology admission, 270 had already been involved in a national cardiovascular registry. Out of these 270 centres which were invited to participate, 170 centres spread throughout France agreed (40 academic hospitals, 109 community hospitals, and 21 private centres). The representativeness of participating centres, stratified by facilities, is specified in Table 1 . Most of them (91%) had an intensive care unit (ICU) or intensive cardiac care unit (ICCU).
The survey involved one cardiologist for each centre who was responsible for patient enrolment and collection of data. Investigators were asked to enroll all patients hospitalized for HF during one day (12 March 2009) no matter what was the specialty of clinical wards. A clinical round was organized in each participating hospital to record all potential patients. Patients were selected if they had signs or symptoms compatible with the diagnosis of AHF, whatever the severity, according to the opinion of the attending investigator based on definitions of European Society of Cardiology (ESC) guidelines. 8 All patients gave informed consent. Local investigators had to confirm the diagnosis of AHF using all available medical records during the hospital course to include the patients definitively.
Data collection
After enrolment, investigators collected data from medical records using a structured case report form (CRF). The patient course as well as clinical data, results of various tests, treatments, and outcome were collected. Clinical presentation of patients was categorized according to clinical scenarios: pulmonary oedema, decompensated HF, cardiogenic shock, isolated right HF, and hypertensive HF, as described in the ESC guidelines. 8 Quality control was performed by an independent physician for a random sample of 150 cases to ensure the accuracy and validity of the data in the CRF, by checking the original clinical records centrally.
Statistical analysis
Results are expressed as median and first and third quartiles (Q1-Q3) or counts and percentage. Differences in patient clinical characteristics for each clinical scenario were tested either by the x 2 test for categorical data or by the Kruskal -Wallis rank test for continuous data. Differences in patient clinical characteristics for LVEF status were tested either by Fisher's exact test for categorical data or by the Wilcoxon rank test for continuous data. The outcome in this study was defined as in-hospital mortality. Associations between single variables and outcome were assessed using a Cox model. As it was a transversal study, patients were included in the analysis only during the follow-up period following their inclusion in the study to avoid any bias in association estimates, i.e. if a patient was included on the 13th day of hospitalization and died on the 21st day, only that period contributed to the likelihood of the Cox model and not the time between hospital admission and death. Hazard ratios (HRs) with a 95% confidence interval (CI) are given as association measures. Proportional hazards assumptions for Cox models were tested. Continuous variables were tested for the log linearity of their effects and dichotomized in the case of non-log linearity. Values used for dichotomization were either a reference value or the median.
To account for missing data, analyses were conducted using a multiple imputation by chained equation approach. All characteristics studied as prognostic factors were included in the imputation regression models as well as the outcome. 13 Results were aggregated over 30 imputed sets using the Rubin rules. 14 Multiple Cox model regression was used to determine a set of variables independently associated with each outcome. The following variables were tested: age .75 years, gender (female vs. male), first medical contact, chronic HF, previous admission for AHF, COPD, diabetes, body mass index (BMI), hypertension, depression, dementia, ischaemic heart disease, valvular disease, acute coronary syndrome (ACS), infection, supraventricular (SV) arrhythmia, cardiogenic shock, systolic blood pressure (per 10 mmHg), heart rate (per 1 b. and LVEF (,30%, 30 -50%, .50%). Variables associated with intervention at a 0.2 level were considered in a multiple model. A backward stepwise variable selection algorithm was performed using a stopping rule based on a P-value cut-off of 0.05. All tests were two-sided using a significance level of 0.05. Analyses were performed using the R statistical package (online at http://www. R-project.org).
Ethical and regulatory considerations
After CRF collection, data were anonymized and stored electronically. The National Committee for Data Processing and for Freedom approved the database format and the anonymization procedure. The survey was registered in clinicaltrials.gov under NCT01080937.
Results

Patient course and use of resources
Among 1868 screened patients, 1658 (89%) with a final diagnosis of AHF and complete data were analysed. Fifty-eight per cent were included in cardiology wards, 18% in ICCU, 3% in ICU, 15% in internal medicine departments, and 6% in emergency departments. Thirty-four per cent were hospitalized in hospitals with cardiac surgery, 36% in hospitals with interventional cardiology, and 29% in others. The patient course before admission was examined: first medical contacts were general practitioners (GPs) in 43% of cases, call to 112 in 25%, and to emergency departments in 19% (Figure 1 ). The number of medical doctors involved in the referral process before admission was one, two, three, or ≥ 4 in 18, 39, 23, and 10% of cases, respectively. Emergency departments were involved in 64% of all cases on admission. The median whole length of hospitalization was 13 days [interquartile range (IQR) 8 -20] . During their whole course, patients stayed in CCU or ICU in 42.9% cases for a median of 4 days (IQR 2-8). Echocardiographic examination, natriuretic peptide testing, and coronary angiography were performed in 81. 5, 82, and 20 Acutely decompensated HF was the most frequent scenario on admission, with 48% of cases; acute pulmonary oedema was present in 38%, while cardiogenic shock, right HF, and hypertensive HF was reported in 6, 6, and 2%, respectively. Differences according to clinical scenarios are reported in Table 2 , except the hypertensive HF group because of its very small size (2%). The main differences were observed in patients with cardiogenic shock as compared with the other scenarios. Isolated right HF was similarly distinguishable from the other scenarios with a mostly preserved LV systolic function, infrequent ischaemic heart disease, and moderately increased levels of natriuretic peptides. In contrast, most of the clinical characteristics were similar in patients with acute pulmonary oedema and acutely decompensated HF, as well as hypertensive HF. Acute heart failure and ACS were associated in 13.4% of cases, and ST-elevation ACS (STE-ACS) in 4.6%. A number of characteristics of patients with ACS were different from those of patients without: more frequent shock or pulmonary oedema (16.4% vs. 4.9% and 56.4 vs. 35 .5%, P , 0.0001), more diabetes (40 vs. 30%, P ¼ 0.002), more history of ischaemic heart disease but less previous hospitalization for HF (64 vs. 29% and 26 vs. 48%, P , 0.0001), and more frequent stays in an ICCU as well as use of coronarography (72% vs. 38% and 57% vs. 16%, P , 0.0001 for both).
In-hospital mortality
A total of 134 (8.2%) in-hospital deaths were reported. Deaths were related to cardiovascular causes in 81% of these cases. Deaths due to non-cardiovascular cause were mainly related to severe infection (7%), acute respiratory distress syndrome, multiorgan failure (5%), and major bleeding (2%). In-hospital mortality was 7.3, 7.4, 13.7, and 16 .8%, respectively, in acute pulmonary oedema, decompensated HF, right HF, and shock (P ¼ 0.003). Variables associated with mortality are shown in Table 3 . Using multivariable analysis, independent predictors on admission were age, systolic blood pressure, serum creatinine, and AF. Figure 2 illustrates changes in risk according to age, systolic blood pressure, and serum creatinine under or above the respective median values. Risk of death reached 18.3% in patients, with all of these variables above their respective median.
Characteristics and treatment at discharge
The main characteristics at discharge, i.e. in survivors, are shown in Table 2 .
Cardiovascular medications at discharge are reported in Table 4 . In patients with LVEF ≤ 40%, i.e. in whom international guidelines can be applied, ACE-Is or ARBs were prescribed in 78% of cases and beta-blockers in 67%; median daily doses reached 50% (25 -50) and 25% (12.5-50) , respectively, of target doses. Parameters significantly associated with the prescription of medications are shown in Table 5 . Aldosterone antagonists were prescribed in 27% of patients with LVEF ≤ 40%. About 10% of patients were discharged without loop diuretics, and the only associated feature was de novo HF (80% of cases).
Device treatments
Implantable cardioverter-defibrillator and CRT were reported to be present in 77 and 72 patients, respectively; 20% were implanted during the hospitalization. Among patients with LVEF ≤ 35%, QRS duration was reported by investigators in two-thirds and was ≥ 120 ms in 41% cases: CRT was reported to be present in 15% of these patients with both LVEF ≤ 35% and QRS ≥ 120 ms. Four patients received a left ventricular assist device and 10 had a heart transplant.
Reduced vs. preserved left ventricular ejection fraction
The LVEF was reported in 1400 patients (84.4% of the whole population), and preserved LVEF ( ≥ 50%) was present in 36. The OFICA study LVEF are shown in Table 6 . In-hospital mortality was higher in patients with reduced EF than in those with preserved EF (8.3% vs. 5.2%, P ¼ 0.039). Treatments at discharge according to LVEF are shown in Table 4 .
Discussion
The OFICA survey is the largest nationwide single-day snapshot. It emphasizes several points of the heterogeneous and complex nature of AHF syndromes as well as overall high severity and remaining unmet needs.
Clinical characteristics
Surveys show that the proportion of elderly patients in the AHF population is increasing continuously. In OFICA, the mean age was 76 years, and nearly 50% of our patients were octogenarians. This is higher than in most others recent registries, 6,15 -18 (Table 7) which could be due to the high representativeness of our population. Underlying cardiac diseases were mainly hypertension and/or coronary artery disease as expected. Valvular diseases, observed in . 20% of the OFICA patients, also emerge as frequent underlying diseases and deserve to be better defined (functional vs. not, mitral regurgitation vs. aortic stenosis, severity) in future HF registries as their impact in HF has been poorly studied to date. Co-morbidities were similar to those reported in most other registries; diabetes, COPD, obesity, and renal failure being the most AHF, acute heart failure; BMI, body mass index; CI, confidence interval; GP, general practitioner; HR, hazard ratio; SV, supraventricular.
Figure 2
In-hospital mortality according to the three main predictive variables-age, blood pressure, and serum creatinineand their value using median as cut-offs. BP, systolic blood pressure, Cr, serum creatinine.
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frequent whatever the LVEF. Precipitating factors have been inconstantly reported in previous surveys. In OFICA, infection and arrhythmia were by far the two most frequent precipitating factors, while ACS were relatively infrequent. Infection as a precipitating factor is well known but has been poorly studied so far. The rate of infection in our survey was higher than in the few registries where it was reported 6, 19, 20 (Table 7) . Such a high prevalence should be further studied by using accurate criteria in order to specify relationships between infection and AHF.
Patient course, use of resources
To date, the AHF patient course before and during hospitalization has been poorly examined. OFICA shows that GPs remain the most frequent first medical contact in France and that they refer patients to emergency departments in most cases. It is important to note that two or three contacts preceded hospitalization in most cases. The clinical impact of such a succession of caregivers before admission may preclude the efficacy of care and deserves further comprehensive analysis. The hospital stay was significantly longer than reported elsewhere 5, 15, 16, 21 (Table 7) , but direct comparison is restricted because of discrepancies in national health systems. This long length of stay remains close to findings in previous French registries over the last two decades, 19, 22 suggesting unmet needs to shorten stays of AHF patients.
In-hospital mortality and predictive criteria
The rate of in-hospital deaths in OFICA, i.e. 8.2%, is higher than that reported in some large registries 16, 17, 20, 21 (Table 7) , but similar to others. 5, 23, 24 These discrepancies could be explained by the less comprehensive nature of some registries as well as by shorter in-hospital stays. Simple and early predictors of outcome are useful. A number of individual variables have been identified previously, 20, 23, 25, 26 and several risk scoring systems have been proposed. 27 In OFICA, multivariable analysis identified only a few independent predictors. The two strongest were age and low blood pressure, followed by renal failure. This is highly comparable with other registries such as the large OPTIMIZE-HF registry. 28 Mortality increases between 50% and 100% each time the value of one of these three variables is above the median as compared with below the median. Otherwise, diabetes and ischaemic heart disease were not predictive, which, though perhaps rather unexpected, has been observed elsewhere. 28 The OFICA study ACS predictive of death, perhaps because there were very few high-risk patients with both ACS and shock. Surprisingly, SV arrhythmia emerged as a 'protective' value, which has never been reported previously. SV arrhythmia may represent a causative factor easy to correct, but the mechanisms of such a 'protective' relationship are not fully clear. Interestingly, admission natriuretic peptide level was reported in most patients. While previous studies 29 -31 have suggested that natriuretic peptide testing could be used as a first-line parameter of AHF scoring, it added no independent prognostic value in our survey.
Clinical scenarios
Among multiple AHF classification schemes, the 2008 European Guidelines defined five clinical scenarios: pulmonary oedema, decompensated HF, cardiogenic shock, hypertensive HF, and isolated right HF. 8 In OFICA, investigators were asked to use these definitions, which gave a preponderance of pulmonary oedema and acutely decompensated HF. The marginal frequency of the hypertensive HF scenario could be due to the strong overlap with the pulmonary oedema scenario and calls into question its usefulness in AHF classification or the need for clearer definition. Patients with cardiogenic shock were significantly different from the others for all clinical characteristics and should definitely be considered separately. Right isolated HF was also distinguishable from the other scenarios in terms of clinical characteristics and in-hospital mortality, which reached 14.3%. The characteristics of right HF have not been well described in previous registries and deserve further dedicated studies. Differences between the two most common scenarios-pulmonary oedema and decompensated HF-were relatively subtle, which indicates how these two scenarios overlap in many aspects and how their differentiation could possibly sometimes be artificial. The high rate of pulmonary oedema in our survey, as compared with others registries (Table 7) , can be due to the absence of restraining criteria (respiratory rate, arterial oxygen saturation, or radiological signs as examples) as well as differences in interpreting of definitions between countries/investigators. Finally, assessing congestion is difficult, and an accurate scoring has been proposed for identifying/ stratifying patients in clinical trials as well as in registries. 32 Clinical scenario was less predictive of mortality than the blood pressure on admission. Admission blood pressure has already been put forward as a means of stratifying patients with AHF. 17, 18 Guidelines also recommend that patients with ACS-associated AHF be considered separately because of specific management as well as specific severity. 12 In OFICA, such a scenario was observed in 13.4% of cases and, while it was associated with shock three times more often than in other patients, in-hospital mortality was not significantly higher in these patients with ACS.
Reduced vs. preserved left ventricular ejection fraction
Despite the high number of elderly patients in OFICA, preserved LVEF was observed in only one-third of the patients under the most recent definition, i.e. LVEF ≥ 50%. 33 However, 55% of our patients had an LVEF ≤ 40%, which is close to that in other registries ( Table 7) . There was a high proportion of both females and elderly patients among those with preserved LVEF. As compared with HF patients with reduced EF, those with preserved EF had similar co-morbidities but exhibited less severe characteristics such as higher mean blood pressure, lower levels of natriuretic peptides, or infrequent shock. While LV dysfunction is a classical predictor of mortality, 33 -35 our survey shows that LVEF is not so relevant for stratifying patients as compared with others predictors such as blood pressure or age for example. Others previous registries have also shown that the prognostic value of LVEF is relatively poor. 19, 21, 23, 26 Treatment Our survey identified several gaps between real-life treatment at discharge and the guidelines in patients with LVEF ≤ 40%:
12 nearly 25% did not have a renin-angiotensin system blocker, one-third had no beta-blocker, and aldosterone antagonists were prescribed in only a quarter of these patients. Some of the reasons for these discrepancies are as expected; as an example, beta-blockers were not prescribed at discharge mainly in patients with COPD. The use of aldosterone antagonists was significantly lower than in previous registries ( Table 7 ) without clear explanation, but may be due to the high proportion of elderly patients as well as the heterogeneity of participating centres in our survey. It will be interesting to monitor their prescription in the future. It is also interesting to underscore the small proportion of patients treated with a device compared with potential candidates for such treatments.
Strengths and limitations
Using a single-day snapshot, we were able to collect high-quality data from a sample of patients which would account for 1% of the estimated annual rate of 180 000 AHF-related hospitalizations in France. 1 About 30% of French hospitals with cardiac units participated. Such a snapshot has an advantage over a registry in that it could be repeated regularly and more easily. In addition, a significant number of patients were included in non-cardiac units. Our survey can thus be taken as a valuable tool as it is representative of the current scope of AHF. On the other hand, OFICA was a single-day snapshot in March and we cannot rule out the possibility that there are significant season-related differences. 37 AHF was the main diagnosis or the cause of admission in most included patients. This could have led investigators to overlook some groups of patients with conditions such as ACS secondarily complicated by AHF, and thus to overlook global severity.
Conclusion
The OFICA survey used an original method-a single-day snapshot in a large number of centres-which avoided some difficulties of registries such as representativeness or comprehensiveness. OFICA is one of the first surveys to analyse patients according to clinical scenarios in addition to LVEF, and the results raise some questions on the usefulness of such classification. OFICA also analysed the patient course before their admission. In-hospital mortality as well as length of stay are high, highlighting the need for further research in this area. Blood pressure on admission as well as renal function firmly emerge as major determinants of overall severity, and definitely help stratify patients as well as orient therapeutic decisions. Regarding treatment at discharge, significant gaps with guidelines remain. OFICA could thus be a useful tool to identify some unsolved issues and pave the way to new strategic programmes in this setting.
